Hepatitis

  • Most Topular Stories

  • A New Hepatitis C Treatment: No Interferon or Ribavirin Required!

    Hepatitis Central
    The Editors at Hepatitis Central
    27 Oct 2014 | 8:09 am
    Harvoni Takes the Sting Out of Hepatitis C Treatment For the first time, hepatitis C can be cured without interferon and ribavirin, which can cause fatigue and depression. Written by David Heitz | October 26, 2014 Finally, there’s a medication to cure hepatitis C that doesn’t require use of the dreaded drugs interferon or ribavirin. The U.S. Food and Drug Administration earlier this month approved Harvoni, a once-daily tablet manufactured by Gilead Sciences. Harvoni is a combination medication that includes sofosbuvir (Sovaldi), another Gilead breakthrough treatment approved late last…
  • Research sheds light on response of the hepatitis C virus to targeted therapeutics

    HCV New Drug Research
    19 Nov 2014 | 6:01 am
    Hepatitis C Antiviral Resistance Revealed Scientists at the Icahn School of Medicine at Mount Sinai (ISMMS) say recent research has shed light on the response of the hepatitis C virus (HCV) to targeted therapeutics and provided new insights about HCV’s role in cancer development. Their work (“Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors”), published in Nature Communications, focused on microRNA genes, a type of regulatory gene, and used whole-genome sequencing of the virus to challenge conventional wisdom about how the virus responds to…
  • Hand soap antimicrobial linked to cancer and liver fibrosis

    Liver Disease / Hepatitis News From Medical News Today
    18 Nov 2014 | 7:00 am
    Researchers say an agent found in shampoo, hand soap and other personal hygiene products - triclosan - caused liver fibrosis and cancer in mice, and it could pose a risk to humans.
  • Intrafamilial spread of hepatitis B virus: some comments.

    MedWorm: Hepatitis B
    20 Nov 2014 | 6:57 am
    Authors: Kabir A, Moghimi M, Amini A PMID: 24596597 [PubMed] (Source: International Journal of Molecular Epidemiology and Genetics)MedWorm Sponsor Message: MedWorm Search is coming back soon. Watch this space...
  • Costly Hep C Drugs Help Drive Spending Jump - WebMD

    hepatitis - Google News
    20 Nov 2014 | 1:29 pm
    RTCostly Hep C Drugs Help Drive Spending JumpWebMDSeveral factors are driving the spending spike, including the introduction of expensive new hepatitis C drugs and fewer drug patent expirations than in previous years, the report found. Such expirations typically lead to savings as cheaper generics Drug spending tops $1 trillion on hepatitis C, cancer therapies: studyReutersall 37 news articles »
 
  • add this feed to my.Alltop

    hepatitis - Google News

  • Costly Hep C Drugs Help Drive Spending Jump - WebMD

    20 Nov 2014 | 1:29 pm
    RTCostly Hep C Drugs Help Drive Spending JumpWebMDSeveral factors are driving the spending spike, including the introduction of expensive new hepatitis C drugs and fewer drug patent expirations than in previous years, the report found. Such expirations typically lead to savings as cheaper generics Drug spending tops $1 trillion on hepatitis C, cancer therapies: studyReutersall 37 news articles »
  • France pegs Gilead hepatitis C drug at "lowest price in Europe" - Reuters

    20 Nov 2014 | 5:23 am
    Bidness ETCFrance pegs Gilead hepatitis C drug at "lowest price in Europe"ReutersPARIS Nov 20 (Reuters) - France has negotiated a big discount for Gilead Sciences Inc's controversial new hepatitis C drug Sovaldi, under a government deal that ensures it will be fully reimbursable by health-funding schemes. The Economic Committee for ...Gilead's hepatitis C drug Harvoni gets marketing authorization in EuropePharmaceutical Business ReviewOoh La La: France Negotiates a Steep Discount for SovaldiWall Street Journal (blog)EU approval for Gilead's hep C combo…
  • County schedules seminar on Hepatitis C - The Edwardsville Intelligencer

    19 Nov 2014 | 10:04 am
    County schedules seminar on Hepatitis CThe Edwardsville IntelligencerNurses will be performing blood draws for anyone interested in being tested for Hepatitis C. The cost is $19 per person for the blood drawing only. There is no cost for attending the presentation. Senior Services Plus is located at 2603 North Rodgers
  • Baby boomers urged to get hepatitis C test - Las Vegas Review-Journal

    18 Nov 2014 | 3:25 pm
    Baby boomers urged to get hepatitis C testLas Vegas Review-JournalWe know you're busy. But, if you can carve out a moment, government health officials have a teensy favor to ask of you. Could you please visit your doctor, sooner rather than later, and get a hepatitis C test? It was in 2012 that the U.S. Centers for and more »
  • Gilead wins European approval of next-generation hepatitis C drug - San Francisco Business Times (blog)

    18 Nov 2014 | 11:09 am
    San Francisco Business Times (blog)Gilead wins European approval of next-generation hepatitis C drugSan Francisco Business Times (blog)Gilead Sciences Inc.'s next-generation hepatitis C drug won European approval Tuesday, opening the door for the drug to be sold in 28 countries. Pricing of Harvoni, which has raised eyebrows at $95,000 in the United States, is a little more complex Gilead Sciences (GILD): Harvoni Marketing Authorization Approved by StreetInsider.com (subscription)Streaming Quotes AreInvestor's Business Dailyall 26 news articles »
  • add this feed to my.Alltop

    About.com Hepatitis: What's Hot Now

  • What's the Difference Between Acute and Chronic...

    hepatitis.guide@about.com
    20 Nov 2014 | 3:13 am
    Hepatitis B is a disease caused by the hepatitis B virus, and can be acute or chronic. Infection with hepatitis B virus is the leading cause of chronic hepatitis worldwide and people with chronic hepatitis B infection are at increased risk for developing liver cancer. In addition, the hepatitis B virus is the leading cause of cirrhosis in the world. Page 2.
  • Why Is Jaundice the Telltale Sign of Hepatitis A?

    hepatitis.guide@about.com
    20 Nov 2014 | 3:13 am
    Hepatitis A is a very contagious disease that's spread by a virus. However, there is good news. It's rarely fatal and doesn't cause chronic disease. Plus, if you have it once, you'll never get it again.
  • The Small Intestines

    hepatitis.guide@about.com
    20 Nov 2014 | 3:13 am
    Hepatitis. Page 5.
  • Tour the Digestive System

    hepatitis.guide@about.com
    20 Nov 2014 | 3:13 am
    The organs of the digestive system work together to digest and absorb food. Let's look at each organ and learn what it does.
  • The Mouth

    hepatitis.guide@about.com
    20 Nov 2014 | 3:13 am
    Hepatitis. Page 2.
 
  • add this feed to my.Alltop

    About.com Hepatitis: Most Popular Articles

  • What Is a "Pegylated" Drug?

    20 Nov 2014 | 4:30 am
    Pegylated interferon is a powerful chronic hepatitis therapy.
  • Protecting Yourself From Medical Mistakes

    20 Nov 2014 | 4:30 am
    In a perfect world, we should trust our physicians, nurses and healthcare providers to, at the very least, not harm us. While many of us have access to well-trained medical providers and most medical care is probably top-notch, we're fooling ourselves if we think mistakes don't or can't happen. Most of these mistakes, I believe, are probably harmless, and I don't worry so much about them. I worry, though, about the mistakes that place us in danger.
  • The 5 Most Common Treatments for Hepatitis

    20 Nov 2014 | 4:30 am
    There are many treatments for hepatitis but which one your physician will use depends on the type of disease. This article describes some of the most common therapies.
  • Immune Globulin for Hepatitis A

    20 Nov 2014 | 4:30 am
    Immune globulin can be used to prevent hepatitis A or even treat hepatitis A after an exposure. Find out how hepatitis A immune globulin can help you.
  • What It Means if Your Doctor Orders an HBsAG Test

    20 Nov 2014 | 4:30 am
    Definition of HBsAG. Hepatitis.
  • add this feed to my.Alltop

    Hepatitis Central

  • Second All-Oral Hep C Treatment Available: Less Expensive

    admin
    13 Nov 2014 | 7:16 am
    J&J Wins U.S. Approval for Hepatitis C Combo With Gilead By Anna Edney Johnson & Johnson (JNJ) won U.S. approval for its hepatitis C drug Olysio to be used in combination with Gilead Sciences Inc. (GILD)’s Sovaldi, making it the second all-oral treatment available for the most common form of the virus. The Food and Drug Administration cleared the once-daily treatment for patients with hepatitis C genotype 1, J&J said yesterday in a statement. The combination allows Olysio to be used without the standard therapies including interferon, an injection that sometimes has flu-like…
  • Harvoni Is Here: The Once-a-Day, Single Hep C Pill

    Nicole Cutler L.Ac.
    12 Nov 2014 | 9:21 am
    The Hepatitis C community has been waiting a long time for a miracle – and Harvoni nearly fits the bill. Approved on October 10, 2014, Harvoni became the first Hepatitis C drug approved by the U.S. Food and Drug Administration (FDA) that does not require the patient to also take interferon or ribavirin. In the form of a once daily pill, Harvoni seems to be the medication many struggling with this infectious disease had been hoping for. Of course, it shouldn’t be surprising that a drug with such fanfare comes with a steep price tag. The U.S. Centers for Disease Control and Prevention…
  • A New Hepatitis C Treatment: No Interferon or Ribavirin Required!

    The Editors at Hepatitis Central
    27 Oct 2014 | 8:09 am
    Harvoni Takes the Sting Out of Hepatitis C Treatment For the first time, hepatitis C can be cured without interferon and ribavirin, which can cause fatigue and depression. Written by David Heitz | October 26, 2014 Finally, there’s a medication to cure hepatitis C that doesn’t require use of the dreaded drugs interferon or ribavirin. The U.S. Food and Drug Administration earlier this month approved Harvoni, a once-daily tablet manufactured by Gilead Sciences. Harvoni is a combination medication that includes sofosbuvir (Sovaldi), another Gilead breakthrough treatment approved late last…
  • How Can Chronic Pain Lead to Hepatitis C?

    Nicole Cutler L.Ac.
    27 Oct 2014 | 7:54 am
    Contracted via blood-to-blood contact, Hepatitis C is an infectious virus of the liver that is easily passed on by sharing intravenous drug needles. At first consideration, Hepatitis C’s mode of transmission appears to have no relationship with chronic muscle, joint, nerve or other type of pain. However, chronic pain that leads to Hepatitis C infection is an alarming pattern that is emerging across the U.S. Chronic Pain Chronic pain is a major public health dilemma. While acute pain is a normal sensation triggered in the nervous system to alert someone of a possible injury, chronic pain is…
  • Dropout Rate for Taking Sovaldi: 400% Higher Than Observed in Clinical Trials

    The Editors at Hepatitis Central
    7 Oct 2014 | 6:47 am
    CVS: One In 12 Hepatitis C Patients Not Adhering To $1,000/Day Pill By David Kroll, 9/17/14 Over 8 percent of hepatitis C patients taking Sovaldi (sofosbuvir; Gilead) are failing to complete their full, 12-week course of drug therapy, a dropout rate roughly four times that observed in clinical trials. By discontinuing the drug, shown to have a 90+% cure rate, these patients (and their insurance providers) are incurring health care costs of $28,000 or $56,000, without knowing if they are rid of the virus. Continue reading this entire article:…
 
  • add this feed to my.Alltop

    Hepatitis News

  • Cellular Origin of Fibrosis Found

    20 Nov 2014 | 11:05 am
    … .g., the liver of a hepatitis C patient, the heart of …
  • Needle exchange seeks funds to fuel services

    20 Nov 2014 | 9:26 am
    … provides testing for HIV and hepatitis C as well as information … they’re going to get hepatitis C especially,” she said. “We … Hamilton County in a new hepatitis C study designed to track … those who are not. While hepatitis C infects 70 percent of …
  • Costly Hepatitis C Treatments Help Drive 12 Percent Drug Spending Jump

    20 Nov 2014 | 8:47 am
    … the introduction of expensive new hepatitis C drugs and fewer drug … the impact of the new hepatitis C drugs declines, less expensive … running about $84,000. Another hepatitis C drug — Harvoni — approved by … Americans have hepatitis C and are potentially eligible for treatment. Hepatitis drug …
  • Pricetags For New Therapies, Generics Push Up Drug Spending

    20 Nov 2014 | 8:47 am
    … Inc's Sovaldi for hepatitis C and new cancer drugs … /20) Kaiser Health News: Costly Hepatitis C Treatments Help Drive 12 … the introduction of expensive new hepatitis C drugs and fewer drug … , a maker of HIV and hepatitis medicines, just bought a coupon …
  • Key Factor Discovered in Progression of Liver Cancer

    20 Nov 2014 | 8:33 am
    … , metabolic diseases and infections with hepatitis C are the most common …
  • add this feed to my.Alltop

    Hepatitis News

  • Increased risk for Hepatitis B seen

    20 Nov 2014 | 12:45 pm
    All content © Copyright 2000 - 2014 WorldNow and WXOW. All Rights Reserved.
  • France pegs Gilead hepatitis C drug at "lowest price in Europe"

    20 Nov 2014 | 6:25 am
    France has negotiated a big discount for Gilead Sciences Inc's controversial new hepatitis C drug Sovaldi, under a government deal that ensures it will be fully reimbursable by health-funding schemes. The Economic Committee for Health Products has fixed the price of a box of Sovaldi at 13,667 euros before tax, a reduction of 5,000 euros on the original price and "the lowest price in Europe", the Health Ministry said on Thursday.
  • Costly, New Hepatitis C Treatments Help Drive 12 Percent Drug Spending Jump

    19 Nov 2014 | 11:15 pm
    After several years of modest increases, American spending on medications is projected to shoot up by 12 percent this year, pushing the nation's drug bill to between $375 billion and $385 billion, according to a report by the IMS Institute for Healthcare Informatics. Several factors are driving the spending spike, including the introduction of expensive new hepatitis C drugs and fewer drug patent expirations than in previous years, the report found.
  • Hepatitis E Virus Genotype 4 in Yak, Northwestern China

    19 Nov 2014 | 10:15 pm
    To the Editor: Hepatitis E virus is a positive-stranded RNA virus with a genome of a 1 , 2 ). On the basis of sequence analysis, mammalian HEVs are classified into 4 recognized genotypes .
  • Hepatic macrophage activation in alcoholic hepatitis

    19 Nov 2014 | 6:12 pm
    A study in November's issue of the American Journal of Gastroenterology investigates hepatic macrophage activation and the lipopolysaccharide pathway in patients with alcoholic hepatitis. Inflammatory activation of resident hepatic macrophages by portal-derived lipopolysaccharide has a primary role in animal models of alcoholic liver disease, but it has not been systematically or longitudinally studied in human alcoholic hepatitis.
 
  • add this feed to my.Alltop

    Hepatitis Blog

  • Red Robin Restaurant Hepatitis A Exposure Class Action lawsuit – Missouri (2014)

    Bill Marler
    28 Oct 2014 | 5:14 pm
    Springfield Missouri Health officials administered more than 5,000 doses of the hepatitis A vaccine. On May 20, 2014, health department officials learned of a food service worker at the Red Robin restaurant who had tested positive for Hepatitis A. Individuals potentially exposed to the Hepatitis A virus dined at the restaurant between May 8 and 16. Marler Clark filed a class action lawsuit against Red Robin restaurant.  The lawsuit was filed on behalf of restaurant patrons who received hepatitis A vaccinations after alleged exposure to the hepatitis A virus at the restaurant between May 8…
  • Hepatitis A Cluster in Alabama

    Bill Marler
    27 Sep 2014 | 9:29 am
    The Alabama Department of Public Health is investigating three cases of hepatitis A in Clarke County in southwest Alabama. The department says two of the cases involve people who have a history of international travel. The health department says signs of hepatitis A appear 15 to 50 days after exposure and commonly include mild fever, loss of appetite, nausea, vomiting and tiredness. The disease varies in severity from about two weeks to six weeks or more. The department says casual contact, such as at an office or school, does not transmit the virus. The risk increases when people are in…
  • 165 Sick with Hepatitis A Linked to Townsend Farms Organic Antioxidant Blend

    Bill Marler
    25 Sep 2014 | 9:52 pm
    165 people were confirmed to have become ill from hepatitis A after eating ‘Townsend Farms Organic Antioxidant Blend’ in 10 states: Arizona (24), California (80), Colorado (29), Hawaii (8), New Hampshire (1), New Jersey (1), New Mexico (11), Nevada (6), Utah (3), and Wisconsin (2). [Note: The cases reported from Wisconsin resulted from exposure to the product in California, the cases reported from New Hampshire reported fruit exposure during travel to Nevada, and the case reported in New Jersey was a household contact of a confirmed case from Colorado.] Eight of the confirmed cases were…
  • Whataburger Linked to Hepatitis A Scare

    Bill Marler
    21 Aug 2014 | 9:12 pm
    Austin Texas health officials are alerting the public about possible hepatitis A exposure at a Whataburger in Central Austin. A restaurant employee there at the 2800 Guadalupe St. location has been diagnosed with the hepatitis A virus. Hepatitis A is a contagious liver disease that is usually spread when a person ingests something that has been contaminated with the feces of an infected person, including contaminated food or water. Signs and symptoms of hepatitis A can include the following Fever Fatigue Loss of appetite Nausea Vomiting Abdominal discomfort Dark urine Clay-colored bowel…
  • Another Reason for Hepatitis A Vaccines – Your Restaurant Remains Closed

    Bill Marler
    19 Jul 2014 | 5:09 am
    Tortilla Marissa’s, a Mexican restaurant in Fort Collins, CO, will not reopen until August 9 because of the Hepatitis A scare that the restaurant faced at the end of June, according to the Coloradoan. The Larimer County Health Department has advised the owners to keep the restaurant closed that long due to the virus’ relatively long incubation period, which averages 28 days but can last up to 50 days in some cases. The restaurant originally closed on June 27, a day after an employee tested positive for the virus, which has a high risk of being spread when an infected person handles…
 
  • add this feed to my.Alltop

    HCV New Drug Research

  • New Hep C Drugs Promise A Cure, For A Big Price

    20 Nov 2014 | 9:38 am
    A new series from Rhode Island Public RadioAt The Crossroads: The Rise Of Hepatitis C And The Fight To Stop ItProgram Update Nov 20At the Crossroads, Part 4: New Hep C Drugs Promise A Cure, For A Big PriceBy KRISTIN GOURLAYThis year marks the 25th anniversary of the discovery of the hepatitis C virus. Since then, people with hepatitis C have had limited – and not very effective – options for treatment.Until now.Revolutionary new treatments have hit the market in just the last few months. But they’re so expensive health insurers are balking at the price.Part four of our series “At the…
  • France pegs Gilead hepatitis C drug at "lowest price in Europe"

    20 Nov 2014 | 9:09 am
    France pegs Gilead hepatitis C drug at "lowest price in Europe"Nov 20 (Reuters) - France has negotiated a big discount forGilead Sciences Inc's controversial new hepatitis C drug Sovaldi, under a government deal that ensures it will be fully reimbursable by health-funding schemes.The Economic Committee for Health Products (CEPS) has fixed the price of a box of Sovaldi at 13,667 euros before tax, a reduction of 5,000 euros on the original price and "the lowest price in Europe", the Health Ministry said on Thursday.Twelve weeks of treatment will now cost 41,000 euros ($51,373) before tax,…
  • Research sheds light on response of the hepatitis C virus to targeted therapeutics

    19 Nov 2014 | 6:01 am
    Hepatitis C Antiviral Resistance Revealed Scientists at the Icahn School of Medicine at Mount Sinai (ISMMS) say recent research has shed light on the response of the hepatitis C virus (HCV) to targeted therapeutics and provided new insights about HCV’s role in cancer development. Their work (“Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors”), published in Nature Communications, focused on microRNA genes, a type of regulatory gene, and used whole-genome sequencing of the virus to challenge conventional wisdom about how the virus responds to…
  • The Dirty Side of Soap - Triclosan found in soaps causes liver fibrosis and cancer in laboratory mice

    19 Nov 2014 | 5:22 am
    The Dirty Side of Soap Triclosan, a common antimicrobial in personal hygiene products, causes liver fibrosis and cancer in mice.Triclosan is an antimicrobial commonly found in soaps, shampoos, toothpastes and many other household items. Despite its widespread use, researchers at University of California, San Diego School of Medicine report potentially serious consequences of long-term exposure to the chemical. The study, published Nov. 17 by Proceedings of the National Academy of Sciences, shows that triclosan causes liver fibrosis and cancer in laboratory mice through molecular…
  • NHS asks Nice to delay ground-breaking hepatitis C drug

    19 Nov 2014 | 4:29 am
    NHS asks Nice to delay ground-breaking hepatitis C drugIt is a drug that cures hepatitis C in 90 per cent of cases and was considered ground-breaking when it came on to the market.Manufactured by Gilead, Sofosbuvir was licenced for use late last year. And in April this year, NHS England took the unusual step of setting up a special access scheme so patients with less than a year to live were able to be treated without waiting for the National Insitute for Health and Care Excellence (Nice) to evaluate whether it should become routinely available on the NHS.But it is expensive – £35,000…
Log in